PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Marc Lémann Selected Research
Azathioprine (Imuran)
09/2008
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
04/2006
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
06/2005
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
01/2002
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate]
Articles by Research Topic
Disease
7
Crohn Disease (Crohn's Disease)
09/2008 - 01/2002
2
Hemorrhage
12/2002 - 08/2002
1
Ulcerative Colitis
01/2007
1
Carcinoma (Carcinomatosis)
06/2005
1
Colitis
12/2002
Drug/Important Bio-Agent (IBA)
4
Azathioprine (Imuran)
FDA Link
Generic
09/2008 - 01/2002
2
infliximab (Remicade)
FDA Link
04/2006 - 02/2006
1
everolimus
IBA
09/2008
1
mica
IBA
06/2007
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2007
1
rofecoxib (Vioxx)
FDA Link
12/2002
1
Erythromycin (Erycette)
FDA Link
Generic
08/2002
1
mycophenolate mofetil (Cellcept)
FDA Link
Generic
01/2002
1
Methotrexate (Mexate)
FDA Link
Generic
01/2002
Therapy/Procedure
1
Laparotomy
02/2007
1
Highly Active Antiretroviral Therapy (HAART)
06/2005